Synapsoft logo
AI Insights from Disclosures
Searching...
IntoCell, Inc. 287840
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
IntoCell, Inc. is an ADC platform technology company researching linkers and drugs in the field of antibody-drug conjugates. ADC is a type of targeted anticancer drug in which a highly active small-molecule substance is linked to an antibody, and it consists of three components: the antibody; the drug; and the linker that connects the antibody and the drug.
Representative Director Park Taegyo
Founded April 1, 2015
Corporation Type KOSDAQ
Industry Classification Research and experimental development on medical sciences and pharmacy
Corporate number 16011-0395354
Business number 274-86-00037
Phone Number 042-716-0083
Fax Number 042-716-0084
Website intocell.com
Company Address 101 Sinildong-ro, Daedeok-gu, Daejeon
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant